Your browser doesn't support javascript.
loading
Sub-cutaneous Pfizer/BioNTech COVID-19 vaccine administration results in seroconversion among young adults.
Friedensohn, Limor; Zur, Meital; Timofeyev, Maxim; Burshtein, Saar; Ben Michael, Yossi; Fink, Noam; Glassberg, Elon.
Affiliation
  • Friedensohn L; Israeli Defense Forces Medical Corps, Israel; Sackler Faculty of Medicine, Tel Aviv University, Tel Aviv, Israel. Electronic address: Limor.fri@gmail.com.
  • Zur M; Israeli Defense Forces Medical Corps, Israel.
  • Timofeyev M; Israeli Defense Forces Medical Corps, Israel.
  • Burshtein S; Israeli Defense Forces Medical Corps, Israel.
  • Ben Michael Y; Israeli Defense Forces Medical Corps, Israel.
  • Fink N; Israeli Defense Forces Medical Corps, Israel.
  • Glassberg E; Israeli Defense Forces Medical Corps, Israel; The Azrieli Faculty of Medicine, Bar-Ilan University, Safed, Israel; Uniformed Services University of the Health Sciences, Bethesda, MD, United States of America.
Vaccine ; 39(42): 6210-6212, 2021 10 08.
Article in En | MEDLINE | ID: mdl-34531083

Full text: 1 Collection: 01-internacional Database: MEDLINE Main subject: COVID-19 Vaccines / COVID-19 Limits: Adult / Humans Language: En Journal: Vaccine Year: 2021 Document type: Article Country of publication: Netherlands

Full text: 1 Collection: 01-internacional Database: MEDLINE Main subject: COVID-19 Vaccines / COVID-19 Limits: Adult / Humans Language: En Journal: Vaccine Year: 2021 Document type: Article Country of publication: Netherlands